Total Funding
$394.5M
Employee Range
251-500
Neurophth is pioneering gene therapy for eye diseases in China. They are the first company dedicated to using genetic treatments for ophthalmic conditions, offering groundbreaking solutions for patients in need.
Neurophth Therapeutics data powered by:
Share
Neurophth Therapeutics data powered by:
Neurophth TherapeuticsOverall Ranking
Neurophth TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
2nd
In Wuhan
Top 8%out of 25 startups
National Rank
Share
66th
In China
Top 6%out of 1186 startups
Regional Rank
Share
90th
In East Asia
Top 5%out of 2082 startups
Neurophth TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Wuhan
Top 17%out of 12 startups
National Rank
Share
25th
In China
Top 5%out of 519 startups
Regional Rank
Share
30th
In East Asia
Top 4%out of 820 startups
rankings by:
Neurophth TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Neurophth TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro